When does Medacta report earnings and why does it matter for MOVE.SW stock

Medacta reports on **13 Mar 2026**. The release matters because guidance and margin detail will drive near-term trading in MOVE.SW stock and clarify growth expectations across regions.

What valuation metrics should investors check for MOVE.SW stock

Monitor PE **36.29**, price-to-book **8.13**, free cash flow per share **1.36**, and inventory days **466.37**. These metrics show premium valuation and working-capital risk for MOVE.SW stock.

What is Meyka AI's view and forecast for MOVE.SW stock

Meyka AI rates MOVE.SW **78.32 (B+, BUY)** and projects a yearly price **CHF 193.66**, model-based and not a guarantee. Use this as one input alongside company guidance.

How liquid is MOVE.SW stock for intraday trading

Average volume is **16,008.00** and today’s volume is **9,258.00**, indicating below-average liquidity. Expect wider spreads and measured position sizing when trading MOVE.SW stock.

CH Stocks

CHF 155.20 MOVE.SW Medacta Group S.A. (SIX) intraday 11 Mar 2026: key earnings to watch

ByDanny Kontos March 11, 2026March 11, 2026

The MOVE.SW stock trades at CHF 155.20 intraday on 11 Mar 2026 ahead of Medacta Group S.A.’s scheduled earnings release on 13 Mar 2026. Investors will watch revenue trends, operating margin and guidance. Key metrics show EPS 4.31 and PE 36.29, while volume sits at 9,258.00 shares. This earnings spotlight links financials to near-term price action and sets expectations for post-report trading